| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
| 08/27/2009 | WO2009103160A1 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 08/27/2009 | WO2009103157A1 Mfap4 as a marker for regulatory cells and anti-cancer cells |
| 08/27/2009 | WO2009103133A1 Genetically modified sequences of trypanosoma cruzi ts and asp-2 antigens, recombinant ts and asp-2 proteins and genetically modified viruses that express the recombinant ts and asp-2 antigens |
| 08/27/2009 | WO2009085864A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/27/2009 | WO2009085859A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/27/2009 | WO2009083249A3 Synthetic analogs of human beta-defensins having antimicrobial, antiviral and chemotactic activity |
| 08/27/2009 | WO2009082440A3 Compositions of toll-like receptor agonists and malaria antigens and methods of use |
| 08/27/2009 | WO2009080823A3 Nerve growth factor conjugates and uses thereof |
| 08/27/2009 | WO2009079212A3 Linked peptide fluorogenic biosensors |
| 08/27/2009 | WO2009078977A3 Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |
| 08/27/2009 | WO2009077134A3 Use of rna for reprogramming somatic cells |
| 08/27/2009 | WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 08/27/2009 | WO2009046453A9 Use of neuregulin-1 in reducing brain damage |
| 08/27/2009 | WO2009041830A9 Cell-permeabilising peptides and polypeptides for microbial cells |
| 08/27/2009 | WO2009036067A3 Molecule production by photosynthetic organisms |
| 08/27/2009 | WO2009009086A3 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression |
| 08/27/2009 | WO2008084402A8 Diagnosis and treatment of alzheimer's and other neurodementing diseases |
| 08/27/2009 | WO2007011859A3 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 08/27/2009 | WO2006096834A3 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 08/27/2009 | WO2004040000A9 G protein coupled receptors and uses thereof |
| 08/27/2009 | US20090217424 Constitutive promoters from poplar and uses thereof |
| 08/27/2009 | US20090217414 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 08/27/2009 | US20090217406 Plant cells and plants with increased tolerance to environmental stress |
| 08/27/2009 | US20090217405 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 08/27/2009 | US20090217391 T1r3 a novel taste receptor |
| 08/27/2009 | US20090216336 Bioresorbable, mineralised material for filling osseous defects |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215994 Novel Centromeric Protein Shugoshin |
| 08/27/2009 | US20090215993 Mycophenolic acid immunogens and antibodies |
| 08/27/2009 | US20090215990 Method and system for production of zein and/or xanthophylls using chromatography |
| 08/27/2009 | US20090215989 Heterologous Protein Production Using The Twin Arginine Translocation Pathway |
| 08/27/2009 | US20090215987 Peptide amidation process |
| 08/27/2009 | US20090215984 Conversion of apoptotic proteins |
| 08/27/2009 | US20090215983 Compounds and methods for inhibiting hepatitis C virus replication |
| 08/27/2009 | US20090215981 Glp-1 Pegylated Compounds |
| 08/27/2009 | US20090215896 Reelin deficiency or dysfunction and methods related thereto |
| 08/27/2009 | US20090215879 Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| 08/27/2009 | US20090215871 Simian adenovirus vectors and methods of use |
| 08/27/2009 | US20090215870 Compositions and methods for targeting of viral vectors |
| 08/27/2009 | US20090215866 Akt ligands and polynucleotides encoding akt ligands |
| 08/27/2009 | US20090215859 Compositions and methods for modulating dhr96 |
| 08/27/2009 | US20090215711 Novel compositions and methods in cancer |
| 08/27/2009 | US20090215701 Enhancement of Iron Chelation Therapy |
| 08/27/2009 | US20090215698 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 08/27/2009 | US20090215696 Toxoplasma gondii Oocyst Protein |
| 08/27/2009 | US20090215695 Regulation of cytokine synthesis and release |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215689 Fgf2-binding peptides and uses thereof |
| 08/27/2009 | US20090215688 GLP-I Agonist And Cardiovascular Complications |
| 08/27/2009 | US20090215686 Nk1-based polypeptides and related methods |
| 08/27/2009 | US20090215683 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 08/27/2009 | US20090215682 Modified PYY (3-36) Peptides and Their Effects on Feeding Behaviour |
| 08/27/2009 | US20090215680 Inhibitor peptides |
| 08/27/2009 | US20090215679 Disease-associated proteins |
| 08/27/2009 | US20090215675 Means for the inhibition of anti-beta1-adrenergic receptor antibodies |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090215670 Site specific pegylated hemoglobin, method of preparing same, and uses thereof |
| 08/27/2009 | US20090215669 Compositions and methods for treatment of diabetes |
| 08/27/2009 | US20090215668 Methods of making and uses of compositions that modulate intronic region-encoded protein function |
| 08/27/2009 | US20090215666 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 08/27/2009 | US20090215665 Compositions and methods for promoting wound healing and tissue regeneration |
| 08/27/2009 | US20090215195 Set1 proteins and uses thereof |
| 08/27/2009 | US20090215174 Methods of inhibiting umami taste receptors |
| 08/27/2009 | US20090215173 PKD Ligands and Polynucleotides Encoding PKD Ligands |
| 08/27/2009 | US20090215172 Methods and Compositions Related to Cyclic Peptide Synthesis |
| 08/27/2009 | US20090215170 Plexin family-like polypeptide, DNA encoding the same and uses thereof |
| 08/27/2009 | US20090215169 Method for regulating protein function in cells using synthetic small molecules |
| 08/27/2009 | US20090215168 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods |
| 08/27/2009 | US20090215151 Two-Step Immunization Procedure Against Chlamydia Infection |
| 08/27/2009 | US20090215149 Membrane proteins; recombinant vectors, cells |
| 08/27/2009 | US20090215135 Novel Gene STS 22 |
| 08/27/2009 | US20090215120 The Use of Protein S Fusion for Protein Solubilization |
| 08/27/2009 | US20090215117 Site specific incorporation of keto amino acids into proteins |
| 08/27/2009 | US20090215113 Methods for purifying pertussis toxin and peptides useful therefor |
| 08/27/2009 | US20090215095 for competitive Enzyme-Linked Immunosorbent Assay using an oxidativly-folded hepcidin polypeptide covalently linked to a hydrophilic spacer that is 2-(2-(aminoethoxy)ethoxy)acetic at the amino terminus of the peptide and to biotin; immobilized antibody |
| 08/27/2009 | US20090215076 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/27/2009 | US20090215071 Methods of targeting baff |
| 08/27/2009 | US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 08/27/2009 | US20090215049 Novel litaf binding site peptides and methods of using the same |
| 08/27/2009 | US20090215046 Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer |
| 08/27/2009 | US20090215044 Receptor in Dendritic Cells |
| 08/27/2009 | US20090214653 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/27/2009 | US20090214603 Synthetic peptides |
| 08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/27/2009 | US20090214588 Vaccines against aids comprising cmv/r-nucleic acid constructs |
| 08/27/2009 | US20090214584 Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis |
| 08/27/2009 | US20090214583 Epitope-enhancement of a human cd4 hiv epitope |
| 08/27/2009 | US20090214582 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof |
| 08/27/2009 | US20090214572 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
| 08/27/2009 | US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases |
| 08/27/2009 | US20090214548 TGR3-Like Protein Receptor |
| 08/27/2009 | US20090214547 Binding member towards pneumolysin |
| 08/27/2009 | US20090214546 Novel therapeutic targets in cancer |
| 08/27/2009 | US20090214537 Serum Resistance Factors of Gram Positive Bacteria |
| 08/27/2009 | US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons |
| 08/27/2009 | US20090214520 Soluble CLCA-1 and antagonists to CLCA-1 |